Completed PHASE3 INTERVENTIONAL 3-arm NCT01357031

Study With Amitriptylin to Evaluate the Efficacy of Melatonin in Treatment of Migraine (EDUMAP)

Double Blind Randomized Study Controlled by Placebo and Amitriptylin to Evaluate the Efficacy of Melatonin in the Preventive Treatment of Migraine

Sponsor: Fundação de Amparo à Pesquisa do Estado de São Paulo

Conditions Migraine

Interventions Amitriptyline Melatonin Placebo

Updated 5 times since 2017 Last updated: Dec 29, 2015 Started: May 31, 2010 Primary completion: Dec 31, 2011 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01357031, this PHASE3 trial focuses on Migraine and remains completed. Sponsored by Fundação de Amparo à Pesquisa do Estado de São Paulo, it has been updated 5 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundação de Amparo à Pesquisa do Estado de São Paulo
Hospital Israelita Albert Einstein

Data source: Hospital Israelita Albert Einstein

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil